217
Views
10
CrossRef citations to date
0
Altmetric
Clinical Features - Original Research

The association between renal function and neurological diseases in type 2 diabetes: a multicenter nationwide cross-sectional study

ORCID Icon, ORCID Icon, , ORCID Icon, & ORCID Icon
Pages 46-52 | Received 08 Sep 2018, Accepted 15 Nov 2018, Published online: 25 Nov 2018

References

  • Ogurtsova K, Da Rocha Fernandes J, Huang Y, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50.
  • Hu FB. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care. 2011;34(6):1249–1257.
  • Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301(20):2129–2140.
  • Deerochanawong C, Ferrario A. Diabetes management in Thailand: a literature review of the burden, costs, and outcomes. Global Health. 2013;9(1):11.
  • Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006;295(2):180–189.
  • Suwanwela NC. Stroke epidemiology in Thailand. J Stroke. 2014;16(1):1.
  • Tesfaye S, Selvarajah D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev. 2012;28(S1):8–14.
  • Tesfaye S, Stevens L, Stephenson J, et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM complications study. Diabetologia. 1996;39(11):1377–1384.
  • Davies M, Brophy S, Williams R, et al. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006;29(7):1518–1522.
  • So WY, Kong AP, Ma RC, et al. Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients. Diabetes Care. 2006;29(9):2046–2052.
  • Masson P, Webster AC, Hong M, et al. Chronic kidney disease and the risk of stroke: a systematic review and meta-analysis. Nephrol Dial Transplant. 2015;30(7):1162–1169.
  • Weiner DE, Tighiouart H, Amin MG, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol. 2004;15(5):1307–1315.
  • Ford I, Bezlyak V, Stott DJ, et al. Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis. PLoS Med. 2009;6(1):e1000016.
  • Go AS, Fang MC, Udaltsova N, et al. Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation. 2009;119(10):1363–1369.
  • Ruilope LM, Zanchetti A, Julius S, et al. Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial. J Hypertens. 2007;25(7):1473–1479.
  • Plengvidhya N, Leelawatana R, Pratipanawatr T, et al. Thailand diabetes registry project: prevalence and risk factors of stroke in thai diabetic patients. J Med Assoc Thai. 2006;89(Suppl 1):S49–53.
  • Lanting LC, Joung IM, Mackenbach JP, et al. Ethnic differences in mortality, end-stage complications, and quality of care among diabetic patients: a review. Diabetes Care. 2005;28(9):2280–2288.
  • Ramachandran A, Snehalatha C, Shetty AS, et al. Trends in prevalence of diabetes in Asian countries. World J Diabetes. 2012;3(6):110.
  • Kennedy WR, Navarro X, Goetz FC, et al. Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med. 1990;322(15):1031–1037.
  • Bolton CF, Baltzan MA, Baltzan RB. Effects of renal transplantation on uremic neuropathy: a clinical and electrophysiologic study. N Engl J Med. 1971;284(21):1170–1175.
  • Medical Research Network of the Consortium of Thai Medical Schools: MedResNet (Thailand). Data Archival for Maximum Utilization System (DAMUS). DM/HT study (NHSO Research Project). 2014 [cited 2018 Aug 8]. http://www.damus.in.th/damus/index.php
  • Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.
  • Nicoletti A, Sofia V, Giuffrida S, et al. Prevalence of stroke: a door-to-door survey in rural Bolivia. Stroke. 2000;31(4):882–885.
  • Danesi M, Okubadejo N, Ojini F. Prevalence of stroke in an urban, mixed-income community in Lagos, Nigeria. Neuroepidemiology. 2007;28(4):216–223.
  • Connor M, Thorogood M, Casserly B, et al. Prevalence of stroke survivors in rural south Africa: results from the Southern Africa Stroke Prevention Initiative (SASPI) Agincourt field site. Stroke. 2004;35(3):627–632.
  • Han M-K, Huh Y, Lee SB, et al. Prevalence of stroke and transient ischemic attack in Korean elders: findings from the Korean Longitudinal Study on Health and Aging (KLoSHA). Stroke. 2009;40(3):966–969.
  • Venketasubramanian N, Tan LC, Sahadevan S, et al. Prevalence of stroke among Chinese, Malay, and Indian Singaporeans: a community-based tri-racial cross-sectional survey. Stroke. 2005;36(3):551–556.
  • Mittelmark M, Psaty BM, Rautaharju PM, et al. Prevalence of cardiovascular diseases among older adults: the cardiovascular health study. Am J Epidemiol. 1993;137(3):311–317.
  • O’Mahony PG, Thomson RG, Dobson R, et al. The prevalence of stroke and associated disability. J Public Health Med. 1999;21(2):166–171.
  • Lee M, Saver JL, Chang K-H, et al. Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ. 2010;341:c4249.
  • Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation. 2007;116(1):85–97.
  • Helmer C, Stengel B, Metzger M, et al. Chronic kidney disease, cognitive decline, and incident dementia the 3C study. Neurology. 2011;77(23):2043–2051.
  • Tamura MK, Wadley V, Yaffe K, et al. Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Am J Kidney Dis. 2008;52(2):227–234.
  • Bugnicourt J-M, Godefroy O, Chillon J-M, et al. Cognitive disorders and dementia in CKD: the neglected kidney-brain axis. J Am Soc Nephrol. 2013;24(3):353–363.
  • Young M, Boulton A, MacLeod A, et al. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36(2):150–154.
  • Abbott CA, Malik RA, van Ross ER, et al. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the UK. Diabetes Care. 2011;34(10):2220–2224.
  • Nitiyanant W, Chetthakul T, Sang-A-kad P, et al. A survey study on diabetes management and complication status in primary care setting in Thailand. J Med Assoc Thai. 2007;90(1):65.
  • Van Acker K, Bouhassira D, De Bacquer D, et al. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics. Diabetes Metab. 2009;35(3):206–213.
  • Hébert HL, Veluchamy A, Torrance N, et al. Risk factors for neuropathic pain in diabetes mellitus. Pain. 2017;158(4):560.
  • Tesfaye S, Malik R, Ward J. Vascular factors in diabetic neuropathy. Diabetologia. 1994;37(9):847–854.
  • Tesfaye S, Chaturvedi N, Eaton SE, et al. Vascular risk factors and diabetic neuropathy. N Engl J Med. 2005;352(4):341–350.
  • Boulton AJ, Vinik AI, Arezzo JC, et al. Diabetic neuropathies: a statement by the American diabetes association. Diabetes Care. 2005;28(4):956–962.
  • Dyck PJ, Davies JL, Wilson DM, et al. Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester diabetic neuropathy study cohort. Diabetes Care. 1999;22(9):1479–1486.
  • Cameron NE, Eaton S, Cotter MA, et al. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia. 2001;44(11):1973–1988.
  • Malik R, Tesfaye S, Thompson S, et al. Endoneurial localisation of microvascular damage in human diabetic neuropathy. Diabetologia. 1993;36(5):454–459.
  • Moody WE, Edwards NC, Madhani M, et al. Endothelial dysfunction and cardiovascular disease in early-stage chronic kidney disease: cause or association? Atherosclerosis. 2012;223(1):86–94.
  • Kaji R, Sumner AJ. Ouabain reverses conduction disturbances in single demyelinated nerve fibers. Neurology. 1989;39(10):1364.
  • Krishnan AV, Phoon RK, Pussell BA, et al. Altered motor nerve excitability in end-stage kidney disease. Brain. 2005;128(9):2164–2174.
  • Kiernan MC, Walters RJL, Andersen KV, et al. Nerve excitability changes in chronic renal failure indicate membrane depolarization due to hyperkalaemia. Brain. 2002;125(6):1366–1378.
  • Craner MJ, Lo AC, Black JA, et al. Abnormal sodium channel distribution in optic nerve axons in a model of inflammatory demyelination. Brain. 2003;126(7):1552–1561.
  • Pop-Busui R, Roberts L, Pennathur S, et al. The management of diabetic neuropathy in CKD. Am J Kidney Dis. 2010;55(2):365–385.
  • Matsushita K, Mahmoodi BK, Woodward M, et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA. 2012;307(18):1941–1951.
  • Botev R, Mallié J-P, Couchoud C, et al. Estimating glomerular filtration rate: Cockcroft–Gault and modification of diet in renal disease formulas compared to renal inulin clearance. Clin J Am Soc Nephrol. 2009;4(5):899–906.
  • Brouns R, De Deyn P. Neurological complications in renal failure: a review. Clin Neurol Neurosurg. 2004;107(1):1–16.
  • Ninomiya T, Perkovic V, Verdon C, et al. Proteinuria and stroke: a meta-analysis of cohort studies. Am J Kidney Dis. 2009;53(3):417–425.
  • Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825–830.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.